These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 39373982)

  • 1. MREDTA: A BERT and transformer-based molecular representation encoder for predicting drug-target binding affinity.
    Sun X; Huang J; Fang Y; Jin Y; Wu J; Wang G; Jia J
    FASEB J; 2024 Oct; 38(19):e70083. PubMed ID: 39373982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting drug-target binding affinity through molecule representation block based on multi-head attention and skip connection.
    Zhang L; Wang CC; Chen X
    Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36411674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 244-MPT overcomes gefitinib resistance in non-small cell lung cancer cells.
    Zhang Y; Yao K; Shi C; Jiang Y; Liu K; Zhao S; Chen H; Reddy K; Zhang C; Chang X; Ryu J; Bode AM; Dong Z; Dong Z
    Oncotarget; 2015 Dec; 6(42):44274-88. PubMed ID: 26517520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Guided Development of Covalent and Mutant-Selective Pyrazolopyrimidines to Target T790M Drug Resistance in Epidermal Growth Factor Receptor.
    Engel J; Smith S; Lategahn J; Tumbrink HL; Goebel L; Becker C; Hennes E; Keul M; Unger A; Müller H; Baumann M; Schultz-Fademrecht C; Günther G; Hengstler JG; Rauh D
    J Med Chem; 2017 Sep; 60(18):7725-7744. PubMed ID: 28853575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Selective and Potent EGFR Inhibitor that Overcomes T790M-Mediated Resistance in Non-Small Cell Lung Cancer.
    Li Y; Song Z; Jin Y; Tang Z; Kang J; Ma X
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27827863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational Computational Design of Fourth-Generation EGFR Inhibitors to Combat Drug-Resistant Non-Small Cell Lung Cancer.
    Park H; Jung HY; Kim K; Kim M; Hong S
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33297461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic and computational-aided integrative drug repositioning strategy for EGFR and ROS1 mutated NSCLC.
    Tripathi V; Khare A; Shukla D; Bharadwaj S; Kirtipal N; Ranjan V
    Int Immunopharmacol; 2024 Sep; 139():112682. PubMed ID: 39029228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of highly potent and selective EGFR
    Yang T; Zhang W; Cao S; Sun S; Cai X; Xu L; Li P; Zheng Z; Li S
    Eur J Med Chem; 2022 Jan; 228():113984. PubMed ID: 34794818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of new thieno[3,2-d]pyrimidine derivatives targeting EGFR
    Chen Y; Yang L; Qiao H; Cheng Z; Xie J; Zhou W; Huang X; Jiang Y; Yu B; Zhao W
    Eur J Med Chem; 2020 Aug; 199():112388. PubMed ID: 32402937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Treatment with Triptolide and Tyrosine Kinase Inhibitors Synergistically Enhances Apoptosis in Non-small Cell Lung Cancer H1975 Cells but Not H1299 Cells through EGFR/Akt Pathway.
    Tong X; Jiang P; Li Y; Guo L; Zhang HM; Zhang BK; Yan M
    Chem Pharm Bull (Tokyo); 2019 Aug; 67(8):864-871. PubMed ID: 31142691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual MET and SMO Negative Modulators Overcome Resistance to EGFR Inhibitors in Human Nonsmall Cell Lung Cancer.
    Morgillo F; Amendola G; Della Corte CM; Giacomelli C; Botta L; Di Maro S; Messere A; Ciaramella V; Taliani S; Marinelli L; Trincavelli ML; Martini C; Novellino E; Ciardiello F; Cosconati S
    J Med Chem; 2017 Sep; 60(17):7447-7458. PubMed ID: 28787156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free energy perturbation guided Synthesis with Biological Evaluation of Substituted Quinoline derivatives as small molecule L858R/T790M/C797S mutant EGFR inhibitors targeting resistance in Non-Small Cell Lung Cancer (NSCLC).
    Karnik KS; Sarkate AP; Tiwari SV; Azad R; Wakte PS
    Bioorg Chem; 2021 Oct; 115():105226. PubMed ID: 34364055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New acrylamide-substituted quinazoline derivatives with enhanced potency for the treatment of EGFR T790M-mutant non-small-cell lung cancers.
    Liu Z; Wang L; Feng M; Yi Y; Zhang W; Liu W; Li L; Liu Z; Li Y; Ma X
    Bioorg Chem; 2018 Apr; 77():593-599. PubMed ID: 29482151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based classification predicts drug response in EGFR-mutant NSCLC.
    Robichaux JP; Le X; Vijayan RSK; Hicks JK; Heeke S; Elamin YY; Lin HY; Udagawa H; Skoulidis F; Tran H; Varghese S; He J; Zhang F; Nilsson MB; Hu L; Poteete A; Rinsurongkawong W; Zhang X; Ren C; Liu X; Hong L; Zhang J; Diao L; Madison R; Schrock AB; Saam J; Raymond V; Fang B; Wang J; Ha MJ; Cross JB; Gray JE; Heymach JV
    Nature; 2021 Sep; 597(7878):732-737. PubMed ID: 34526717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covalent vs. Non-Covalent Inhibition: Tackling Drug Resistance in EGFR - A Thorough Dynamic Perspective.
    Akher FB; Farrokhzadeh A; Soliman MES
    Chem Biodivers; 2019 Mar; 16(3):e1800518. PubMed ID: 30548188
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    McMahon NP; Solanki A; Wang LG; Montaño AR; Jones JA; Samkoe KS; Tichauer KM; Gibbs SL
    Theranostics; 2024; 14(7):2816-2834. PubMed ID: 38773974
    [No Abstract]   [Full Text] [Related]  

  • 17. TransVAE-DTA: Transformer and variational autoencoder network for drug-target binding affinity prediction.
    Zhou C; Li Z; Song J; Xiang W
    Comput Methods Programs Biomed; 2024 Feb; 244():108003. PubMed ID: 38181572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of (R)-1-(3-(4-Amino-3-(3-chloro-4-(pyridin-2-ylmethoxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one (CHMFL-EGFR-202) as a Novel Irreversible EGFR Mutant Kinase Inhibitor with a Distinct Binding Mode.
    Wang A; Li X; Wu H; Zou F; Yan XE; Chen C; Hu C; Yu K; Wang W; Zhao P; Wu J; Qi Z; Wang W; Wang B; Wang L; Ren T; Zhang S; Yun CH; Liu J; Liu Q
    J Med Chem; 2017 Apr; 60(7):2944-2962. PubMed ID: 28282122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of small-molecule EGFR allosteric inhibitors by high-throughput docking.
    Caporuscio F; Tinivella A; Restelli V; Semrau MS; Pinzi L; Storici P; Broggini M; Rastelli G
    Future Med Chem; 2018 Jul; 10(13):1545-1553. PubMed ID: 29766737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel, selective acrylamide linked quinazolines for the treatment of double mutant EGFR-L858R/T790M Non-Small-Cell lung cancer (NSCLC).
    Pawara R; Ahmad I; Nayak D; Wagh S; Wadkar A; Ansari A; Belamkar S; Surana S; Nath Kundu C; Patil C; Patel H
    Bioorg Chem; 2021 Oct; 115():105234. PubMed ID: 34399322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.